Department of Neurology, Xiangya Hospital, Central South University, 87 Xiang Ya Road, Changsha, 410008, Hunan, People's Republic of China.
Mol Biol Rep. 2012 Apr;39(4):4509-18. doi: 10.1007/s11033-011-1241-0. Epub 2011 Sep 28.
The functionality of endothelial cells is fundamental for the homoeostasis of the vascular system. Increasing evidence shows that endothelial inflammation and senescence contribute greatly to multiple vascular diseases including atherosclerosis. However, little is known regarding the complex upstream regulators of gene expression and translation involved in these responses. MicroRNAs (miRNAs) have emerged as a novel class of endogenous, small, non-coding RNAs that negatively regulate over 30% of genes in a cell via degradation or translational inhibition of their target mRNAs. During the past few years, miRNAs have emerged as key regulators for endothelial biology and function. Endothelial inflammation is critically regulated by miRNAs such as miR-126 and miR-10a in vitro and in vivo. Endothelial aging is additionally controlled by miR-217 and miR-34a. In this review, we summarize the role of miRNAs and their target genes in endothelial inflammation and senescence, and discuss their applicability as drug targets.
内皮细胞的功能对于血管系统的稳态至关重要。越来越多的证据表明,内皮炎症和衰老极大地促进了多种血管疾病,包括动脉粥样硬化。然而,对于参与这些反应的复杂的上游基因表达和翻译调控因子知之甚少。微小 RNA(miRNA)是一类新的内源性、小的非编码 RNA,它们通过降解或翻译抑制靶 mRNA,负调控细胞中超过 30%的基因。在过去的几年中,miRNA 已成为内皮生物学和功能的关键调控因子。miRNA 如 miR-126 和 miR-10a 在体外和体内都能对内皮炎症进行严格调控。miR-217 和 miR-34a 还控制着内皮衰老。在这篇综述中,我们总结了 miRNA 及其靶基因在血管内皮炎症和衰老中的作用,并讨论了它们作为药物靶点的适用性。